BioPharma Dive December 9, 2024

Sponsored content By Greater Phoenix Economic Council (GPEC)

When Mayo Clinic was evaluating a massive investment to build a biotechnology innovation hub in the Phoenix area, leaders considered many attributes in the Valley of the Sun, including access to land, talent and workforce development, attractiveness to new movers, ease of travel, as well as world-class healthcare and clinical research in a business-friendly environment.

These qualities have helped the Greater Phoenix region quietly emerge as a leader for bioscience and healthcare innovation, and Mayo Clinic saw an opportunity to contribute to—and build upon—that momentum.

Set to open in 2027, phase one of Mayo’s Discovery Oasis development will establish a cutting-edge ecosystem where biotechnology companies, researchers, educators and healthcare providers converge to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
How has U.S. Spending on Health Care Changed Over Time?
Merck enters $2B licensing deal for weight loss drug
How Medicare Negotiated Drug Prices Compare to Other Countries
The Fed's Warnings On Inflation Are Bad News For Biotech Startups
AI Tech Firm SandboxAQ Adds $300M to Ramp Up Development of LQMs for Drug Discovery & More

Share This Article